Medtronic Purchases Implant 'Envelope' Developer for $160M

Minneapolis-based Medtronic purchased New Jersey-based Tyrx for $160 million, according to a Minneapolis/St. Paul Business Journal report. Tyrx produces antibacterial pouches, or envelopes, for medical devices to reduce risk of infection following device implantation. The company's main product is the AIGISRx Antibacterial Envelope, which is placed around implants prior to implantation and eventually dissolve after releasing antimicrobial agents.

Tyrx's pouches have been cleared to use with spinal cord stimulators and cardiac implants.

More Articles on Devices:
19 Spine Devices Receive FDA 510(k) Clearance in December
DePuy Synthes Spine Launches Bone Matrix Tissue Implant for Spinal Fusion
SI-BONE Celebrates 10k iFuse Implant System Uses Worldwide